Free Trial

Ingredion (INGR) Financials

Ingredion logo
$106.08 -0.69 (-0.64%)
Closing price 05/13/2026 03:59 PM Eastern
Extended Trading
$101.68 -4.40 (-4.14%)
As of 09:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Ingredion

Annual Income Statements for Ingredion

This table shows Ingredion's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
402 485 519 443 413 348 117 492 643 647 729
Consolidated Net Income / (Loss)
412 496 532 454 424 354 125 502 651 654 736
Net Income / (Loss) Continuing Operations
412 496 532 454 424 354 125 502 651 654 736
Total Pre-Tax Income
599 742 769 621 582 506 248 668 839 931 974
Total Operating Income
660 806 836 703 664 582 310 762 957 883 1,016
Total Gross Profit
1,242 1,401 1,472 1,368 1,312 1,272 1,331 1,494 1,749 1,791 1,828
Total Revenue
5,621 5,704 6,244 6,289 6,209 5,987 6,894 7,946 8,160 7,430 7,219
Operating Revenue
5,621 5,704 6,244 6,289 6,209 5,987 6,894 7,946 8,160 7,430 7,219
Total Cost of Revenue
4,379 4,303 4,772 4,921 4,897 4,715 5,563 6,452 6,411 5,639 5,391
Operating Cost of Revenue
4,379 4,303 4,772 4,921 4,897 4,715 5,563 6,452 6,411 5,639 5,391
Total Operating Expenses
582 595 636 665 648 690 1,021 732 792 908 812
Selling, General & Admin Expense
- - 616 611 610 628 668 715 789 782 815
Other Operating Expenses / (Income)
-1.00 -4.00 -18 -10 -19 -31 -34 13 -8.00 -1.00 -24
Restructuring Charge
583 599 38 64 57 93 387 4.00 11 127 21
Total Other Income / (Expense), net
-61 -64 -67 -82 -82 -76 -62 -94 -118 48 -42
Interest Expense
61 66 73 86 81 81 74 99 114 39 37
Other Income / (Expense), net
- 2.00 6.00 4.00 -1.00 5.00 12 5.00 -4.00 87 -5.00
Income Tax Expense
187 246 237 167 158 152 123 166 188 277 238
Net Income / (Loss) Attributable to Noncontrolling Interest
10 11 13 11 11 6.00 8.00 10 8.00 7.00 7.00
Basic Earnings per Share
$5.62 $6.70 $7.21 $6.25 $6.17 $5.18 $1.74 $7.43 $9.74 $9.88 $11.36
Weighted Average Basic Shares Outstanding
71.60M 72.30M 72M 70.90M 66.90M 67.20M 67.10M 66.20M 66M 65.50M 64.20M
Diluted Earnings per Share
$5.51 $6.55 $7.06 $6.17 $6.13 $5.15 $1.73 $7.34 $9.60 $9.71 $11.18
Weighted Average Diluted Shares Outstanding
73M 74.10M 73.50M 71.80M 67.40M 67.60M 67.80M 67M 67M 66.60M 65.20M
Weighted Average Basic & Diluted Shares Outstanding
71.50M 72.40M 72M 70.90M 66.88M 67.11M 66.71M 65.95M 65.56M 64.19M 62.95M
Cash Dividends to Common per Share
- $1.90 $2.20 $2.45 $2.51 $2.54 $2.58 $2.72 $2.98 $3.16 $3.24

Quarterly Income Statements for Ingredion

This table shows Ingredion's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
158 131 216 148 188 95 197 196 171 165 142
Consolidated Net Income / (Loss)
160 133 218 150 189 97 199 198 172 167 144
Net Income / (Loss) Continuing Operations
160 133 218 150 189 97 199 198 172 167 144
Total Pre-Tax Income
185 176 276 230 273 152 267 259 241 207 194
Total Operating Income
213 202 213 240 268 162 276 271 249 220 203
Total Gross Profit
421 400 417 446 479 449 466 477 455 430 401
Total Revenue
2,033 1,921 1,882 1,878 1,870 1,800 1,813 1,833 1,816 1,757 1,792
Operating Revenue
2,033 1,921 1,882 1,878 1,870 1,800 1,813 1,833 1,816 1,757 1,792
Total Cost of Revenue
1,612 1,521 1,465 1,432 1,391 1,351 1,347 1,356 1,361 1,327 1,391
Operating Cost of Revenue
1,612 1,521 1,465 1,432 1,391 1,351 1,347 1,356 1,361 1,327 1,391
Total Operating Expenses
208 198 204 206 211 287 190 206 206 210 198
Selling, General & Admin Expense
203 211 189 191 198 204 193 208 203 211 200
Other Operating Expenses / (Income)
-5.00 -14 12 -8.00 1.00 -6.00 -10 -5.00 0.00 -9.00 -13
Restructuring Charge
10 1.00 3.00 23 12 89 7.00 3.00 3.00 8.00 11
Total Other Income / (Expense), net
-28 -26 63 -10 5.00 -10 -9.00 -12 -8.00 -13 -9.00
Interest Expense
26 26 19 10 1.00 9.00 9.00 12 7.00 9.00 9.00
Income Tax Expense
25 43 58 80 84 55 68 61 69 40 50
Net Income / (Loss) Attributable to Noncontrolling Interest
2.00 2.00 2.00 2.00 1.00 2.00 2.00 2.00 1.00 2.00 2.00
Basic Earnings per Share
$2.39 $2.00 $3.29 $2.25 $2.88 $1.46 $3.05 $3.04 $2.66 $2.61 $2.25
Weighted Average Basic Shares Outstanding
66M 66M 65.70M 65.70M 65.30M 65.50M 64.50M 64.50M 64.30M 64.20M 63.20M
Diluted Earnings per Share
$2.36 $1.97 $3.23 $2.22 $2.83 $1.43 $3.00 $2.99 $2.61 $2.58 $2.22
Weighted Average Diluted Shares Outstanding
67M 67M 66.80M 66.80M 66.50M 66.60M 65.60M 65.60M 65.40M 65.20M 64M
Weighted Average Basic & Diluted Shares Outstanding
65.19M 65.56M 65.65M 65.06M 65.16M 64.19M 64.31M 64.18M 63.53M 62.95M 63.06M
Cash Dividends to Common per Share
$0.78 - $0.78 $0.78 $0.80 - $0.80 $0.80 $0.82 - $0.82

Annual Cash Flow Statements for Ingredion

This table details how cash moves in and out of Ingredion's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-146 82 83 -247 -63 401 -337 -92 165 596 33
Net Cash From Operating Activities
686 771 769 703 680 829 392 152 1,057 1,436 944
Net Cash From Continuing Operating Activities
686 771 769 703 680 829 392 152 1,057 1,436 944
Net Income / (Loss) Continuing Operations
412 496 532 454 424 354 125 502 651 654 736
Consolidated Net Income / (Loss)
412 496 532 454 424 354 125 502 651 654 736
Depreciation Expense
194 196 209 247 220 213 220 215 219 214 222
Non-Cash Adjustments To Reconcile Net Income
106 101 105 96 90 159 403 112 131 113 120
Changes in Operating Assets and Liabilities, net
-26 -22 -77 -94 -54 103 -356 -677 56 455 -134
Net Cash From Investing Activities
-649 -689 -326 -361 -374 -571 -335 -320 -329 -47 -444
Net Cash From Continuing Investing Activities
-649 -689 -326 -361 -374 -571 -335 -320 -329 -47 -444
Purchase of Property, Plant & Equipment
-280 -284 -314 -350 -328 -340 -300 -300 -314 -295 -433
Purchase of Investments
- -2.00 -3.00 -15 - - - - -9.00 -4.00 -20
Divestitures
- - - - - - - 0.00 0.00 255 12
Other Investing Activities, net
- - - 2.00 -6.00 -2.00 -13 2.00 -6.00 -3.00 -3.00
Net Cash From Financing Activities
-116 0.00 -375 -589 -364 143 -373 103 -569 -765 -491
Net Cash From Continuing Financing Activities
-116 0.00 -375 -589 -364 143 -373 103 -569 -765 -491
Repayment of Debt
-1,366 - -1,240 -738 -1,465 -1,233 -1,440 -532 -1,012 -1,118 -449
Repurchase of Common Equity
-41 -8.00 -123 -657 66 0.00 -68 -158 -103 -256 -224
Payment of Dividends
-126 141 -165 -182 -174 -178 -184 -181 -194 -210 -211
Issuance of Debt
1,388 1,880 1,144 987 1,209 1,550 1,300 965 720 773 405
Other Financing Activities, net
8.00 - - - - - - - 20 46 -12
Effect of Exchange Rate Changes
-67 - - - - 0.00 -21 -27 6.00 -28 24

Quarterly Cash Flow Statements for Ingredion

This table details how cash moves in and out of Ingredion's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
78 66 37 67 372 120 -160 24 54 115 -116
Net Cash From Operating Activities
368 410 209 312 479 436 77 185 277 405 33
Net Cash From Continuing Operating Activities
368 410 209 312 479 436 77 185 277 405 33
Net Income / (Loss) Continuing Operations
160 133 218 150 189 97 199 198 172 167 144
Consolidated Net Income / (Loss)
160 133 218 150 189 97 199 198 172 167 144
Depreciation Expense
56 54 53 54 53 54 55 53 57 57 55
Non-Cash Adjustments To Reconcile Net Income
40 31 -36 37 6.00 106 37 23 24 36 29
Changes in Operating Assets and Liabilities, net
112 192 -26 71 231 179 -214 -89 24 145 -195
Net Cash From Investing Activities
-82 -87 181 -56 -46 -126 -78 -125 -87 -142 -100
Net Cash From Continuing Investing Activities
-82 -87 181 -56 -46 -126 -78 -125 -87 -142 -100
Purchase of Property, Plant & Equipment
-79 -83 -65 -55 -50 -131 -92 -101 -105 -135 -110
Purchase of Investments
- - - - - - 0.00 - 8.00 -9.00 -1.00
Divestitures
- - 247 - 8.00 - 12 - 12 - 12
Other Investing Activities, net
-4.00 -4.00 -1.00 -1.00 -4.00 -1.00 2.00 -5.00 -2.00 2.00 -1.00
Net Cash From Financing Activities
-204 -268 -347 -179 -75 -164 -166 -50 -136 -151 -48
Net Cash From Continuing Financing Activities
-204 -268 -347 -179 -75 -164 -166 -50 -136 -151 -48
Repayment of Debt
-199 -303 -446 143 -563 -252 -154 -111 -96 -88 -123
Repurchase of Common Equity
-103 - -1.00 -105 -21 -129 -55 - -79 -90 -21
Payment of Dividends
-48 -51 -51 -53 -52 -54 -52 -54 -51 -54 -52
Issuance of Debt
143 84 149 -173 551 246 106 125 93 81 158
Other Financing Activities, net
- - 2.00 - - - -11 -10 -3.00 - -10
Effect of Exchange Rate Changes
-4.00 11 -6.00 -10 14 -26 7.00 14 - 3.00 -1.00

Annual Balance Sheets for Ingredion

This table presents Ingredion's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
5,074 5,782 6,080 5,728 6,040 6,858 6,999 7,561 7,642 7,444 7,897
Total Current Assets
1,950 2,252 2,415 2,138 2,160 2,647 2,697 3,309 3,399 3,355 3,505
Cash & Equivalents
434 512 595 327 264 665 328 236 401 997 1,030
Short-Term Investments
6.00 4.00 9.00 7.00 4.00 0.00 4.00 3.00 8.00 11 3.00
Accounts Receivable
775 923 961 951 977 1,011 1,130 1,411 1,279 1,093 1,185
Inventories, net
715 789 823 824 861 917 1,172 1,597 1,450 1,187 1,227
Prepaid Expenses
20 24 27 29 54 54 63 62 261 67 60
Plant, Property, & Equipment, net
1,989 2,116 2,217 2,198 2,306 2,455 2,423 2,407 2,370 2,264 2,526
Total Noncurrent Assets
1,135 1,414 1,448 1,392 1,574 1,756 1,879 1,845 1,873 1,825 1,866
Goodwill
601 784 803 791 801 1,346 1,348 1,301 1,303 1,264 922
Intangible Assets
410 502 493 460 437 - - - - - 347
Other Noncurrent Operating Assets
117 121 143 131 323 410 531 544 570 561 597
Total Liabilities & Shareholders' Equity
5,074 5,782 6,080 5,728 6,040 6,858 6,999 7,561 7,642 7,444 7,897
Total Liabilities
2,894 3,157 3,127 3,283 3,268 3,786 3,774 4,299 3,992 3,554 3,531
Total Current Liabilities
742 978 957 946 967 1,458 1,512 1,882 1,772 1,281 1,316
Short-Term Debt
19 106 120 169 82 438 308 543 448 44 48
Accounts Payable
423 440 493 452 504 599 774 873 778 604 693
Other Current Liabilities
- - - - - - - 466 546 633 575
Total Noncurrent Liabilities
2,152 2,179 2,170 2,337 2,301 2,328 2,262 2,417 2,220 2,273 2,215
Long-Term Debt
1,989 2,008 1,971 1,931 1,766 2,328 2,262 2,417 2,220 2,273 2,215
Redeemable Noncontrolling Interest
- 30 36 37 31 100 107 99 98 67 71
Total Equity & Noncontrolling Interests
2,180 2,595 2,917 2,408 2,741 2,972 3,118 3,163 3,552 3,823 4,295
Total Preferred & Common Equity
2,144 2,565 2,891 2,388 2,720 2,951 3,100 3,147 3,538 3,804 4,274
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,144 2,565 2,891 2,388 2,720 2,951 3,100 3,147 3,538 3,804 4,274
Common Stock
1,161 1,150 1,139 1,097 1,138 1,151 1,159 1,133 1,147 1,153 1,156
Retained Earnings
2,552 2,899 3,259 3,536 3,780 3,957 3,899 4,210 4,654 5,092 5,610
Accumulated Other Comprehensive Income / (Loss)
-1,102 -1,071 -1,013 -1,154 -1,158 -1,133 -897 -1,048 -1,056 -1,086 -937
Other Equity Adjustments
-467 -413 -494 -1,091 -1,040 - -1,061 - -1,207 -1,355 -1,555
Noncontrolling Interest
36 30 26 20 21 21 18 16 14 19 21

Quarterly Balance Sheets for Ingredion

This table presents Ingredion's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
7,403 7,645 7,600 7,549 7,319 7,221 7,525 7,468 7,781 7,833 7,928
Total Current Assets
3,268 3,402 3,311 3,289 3,125 3,099 3,351 3,365 3,517 3,516 3,525
Cash & Equivalents
294 216 257 335 438 505 877 837 861 915 914
Short-Term Investments
4.00 5.00 6.00 6.00 7.00 5.00 7.00 9.00 7.00 6.00 4.00
Accounts Receivable
1,406 1,455 1,366 1,380 1,284 1,286 1,173 1,284 1,359 1,312 1,358
Inventories, net
1,500 1,663 1,618 1,502 1,344 1,244 1,234 1,172 1,223 1,225 1,183
Prepaid Expenses
64 63 64 66 52 59 60 63 67 58 66
Plant, Property, & Equipment, net
2,308 2,397 2,414 2,401 2,334 2,291 2,332 2,289 2,361 2,435 2,561
Total Noncurrent Assets
1,827 1,846 1,875 1,859 1,860 1,831 1,842 1,814 1,903 1,882 1,842
Goodwill
1,286 1,297 1,311 1,296 1,286 1,275 1,295 1,264 1,280 1,273 920
Intangible Assets
- - - - - - - - - - 339
Other Noncurrent Operating Assets
541 549 564 563 574 556 547 550 623 609 583
Total Liabilities & Shareholders' Equity
7,403 7,645 7,600 7,549 7,319 7,221 7,525 7,468 7,781 7,833 7,928
Total Liabilities
4,224 4,280 4,125 4,082 3,494 3,442 3,495 3,420 3,505 3,509 3,482
Total Current Liabilities
1,949 1,892 1,720 1,668 1,283 1,230 1,255 1,182 1,264 1,278 1,277
Short-Term Debt
709 701 522 466 141 109 99 42 46 57 83
Accounts Payable
1,240 1,191 1,198 1,202 659 606 604 634 666 652 613
Other Current Liabilities
- - - - 483 515 552 506 552 569 581
Total Noncurrent Liabilities
2,275 2,388 2,405 2,414 2,211 2,212 2,240 2,238 2,241 2,231 2,205
Long-Term Debt
2,275 2,388 2,405 2,414 2,211 2,212 2,240 2,238 2,241 2,231 2,205
Redeemable Noncontrolling Interest
99 89 86 90 85 57 61 50 58 65 41
Total Equity & Noncontrolling Interests
3,080 3,276 3,389 3,377 3,740 3,722 3,969 3,998 4,218 4,259 4,405
Total Preferred & Common Equity
3,066 3,263 3,377 3,364 3,724 3,705 3,950 3,977 4,197 4,238 4,383
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
3,066 3,263 3,377 3,364 3,724 3,705 3,950 3,977 4,197 4,238 4,383
Common Stock
1,134 1,134 1,143 1,144 1,147 1,142 1,146 1,159 1,161 1,157 1,163
Retained Earnings
4,143 4,354 4,469 4,575 4,818 4,914 5,049 5,236 5,380 5,497 5,700
Accumulated Other Comprehensive Income / (Loss)
-1,052 -1,098 -1,119 -1,144 -1,062 -1,118 -1,000 -1,025 -953 -950 -927
Other Equity Adjustments
-1,159 - -1,116 -1,211 -1,179 - -1,245 -1,393 -1,391 -1,466 -1,553
Noncontrolling Interest
14 13 12 13 16 17 19 21 21 21 22

Annual Metrics And Ratios for Ingredion

This table displays calculated financial ratios and metrics derived from Ingredion's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-0.83% 1.48% 9.47% 0.72% -1.27% -3.58% 15.15% 15.26% 2.69% -8.95% -2.84%
EBITDA Growth
10.05% 17.56% 4.68% -9.23% -7.44% -9.40% -32.25% 81.18% 19.35% 1.02% 4.14%
EBIT Growth
13.60% 22.42% 4.21% -16.03% -6.22% -11.46% -45.14% 138.20% 24.25% 1.78% 4.23%
NOPAT Growth
11.93% 18.69% 7.34% -11.14% -5.88% -15.83% -61.63% 266.49% 29.67% -16.47% 23.77%
Net Income Growth
13.50% 20.39% 7.26% -14.66% -6.61% -16.51% -64.69% 301.60% 29.68% 0.46% 12.54%
EPS Growth
16.24% 18.87% 7.79% -12.61% -0.65% -15.99% -66.41% 324.28% 30.79% 1.15% 15.14%
Operating Cash Flow Growth
-6.16% 12.39% -0.26% -8.58% -3.27% 21.91% -52.71% -61.22% 595.39% 35.86% -34.26%
Free Cash Flow Firm Growth
-43.31% -76.97% 466.54% 105.60% -53.87% -220.74% 67.68% 139.36% 1,451.19% 62.91% -72.13%
Invested Capital Growth
4.96% 12.67% 5.14% -5.16% 3.35% 18.86% 5.61% 9.52% -1.24% -12.02% 7.64%
Revenue Q/Q Growth
2.09% -0.09% 7.75% 0.40% -4.97% 0.74% 2.41% 3.01% -0.80% -1.60% -0.59%
EBITDA Q/Q Growth
6.88% 1.83% 2.34% -3.83% 1.61% -1.11% -10.12% 5.82% 3.81% -3.35% 4.94%
EBIT Q/Q Growth
8.91% 2.15% 2.56% -5.86% 1.69% -0.34% -18.07% 9.10% 4.84% -4.06% 5.75%
NOPAT Q/Q Growth
11.80% -2.14% 0.85% 0.21% 3.47% 1.23% -26.95% 13.29% 1.23% -6.99% 10.58%
Net Income Q/Q Growth
12.02% -1.98% 1.14% -1.30% 3.92% 0.85% -27.75% 10.33% 2.84% -5.22% 10.51%
EPS Q/Q Growth
11.76% -2.09% 1.00% 0.65% 4.07% 1.58% -28.22% 10.38% 2.78% -5.27% 11.47%
Operating Cash Flow Q/Q Growth
-8.53% 3.21% 2.12% -14.68% 10.75% 10.24% -25.48% -28.64% 47.01% 1.84% -3.18%
Free Cash Flow Firm Q/Q Growth
132.62% -88.29% 14,557.88% 22.83% -37.29% -325.87% 33.82% 111.74% 37.81% 11.99% -24.07%
Invested Capital Q/Q Growth
-3.03% 9.09% -0.16% -3.31% 1.78% 15.08% 11.24% 2.01% -1.62% -5.21% -1.67%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
22.10% 24.56% 23.57% 21.75% 21.13% 21.25% 19.31% 18.80% 21.43% 24.11% 25.32%
EBITDA Margin
15.19% 17.60% 16.83% 15.17% 14.22% 13.36% 7.86% 12.36% 14.36% 15.94% 17.08%
Operating Margin
11.74% 14.13% 13.39% 11.18% 10.69% 9.72% 4.50% 9.59% 11.73% 11.88% 14.07%
EBIT Margin
11.74% 14.17% 13.48% 11.24% 10.68% 9.80% 4.67% 9.65% 11.68% 13.06% 14.00%
Profit (Net Income) Margin
7.33% 8.70% 8.52% 7.22% 6.83% 5.91% 1.81% 6.32% 7.98% 8.80% 10.20%
Tax Burden Percent
68.78% 66.85% 69.18% 73.11% 72.85% 69.96% 50.40% 75.15% 77.59% 70.25% 75.56%
Interest Burden Percent
90.76% 91.83% 91.33% 87.84% 87.78% 86.20% 77.02% 87.09% 88.04% 95.98% 96.34%
Effective Tax Rate
31.22% 33.15% 30.82% 26.89% 27.15% 30.04% 49.60% 24.85% 22.41% 29.75% 24.44%
Return on Invested Capital (ROIC)
12.40% 13.52% 13.35% 11.88% 11.30% 8.55% 2.94% 10.01% 12.49% 11.17% 14.22%
ROIC Less NNEP Spread (ROIC-NNEP)
9.54% 10.82% 10.35% 8.20% 7.73% 5.66% 1.50% 7.16% 8.81% 13.06% 11.72%
Return on Net Nonoperating Assets (RNNOA)
6.38% 7.13% 5.72% 4.94% 4.96% 3.57% 1.03% 5.47% 6.35% 6.18% 3.61%
Return on Equity (ROE)
18.78% 20.65% 19.07% 16.82% 16.25% 12.12% 3.97% 15.48% 18.84% 17.35% 17.83%
Cash Return on Invested Capital (CROIC)
7.57% 1.60% 8.34% 17.18% 8.01% -8.69% -2.52% 0.92% 13.73% 23.95% 6.87%
Operating Return on Assets (OROA)
12.99% 14.89% 14.20% 11.97% 11.27% 9.10% 4.65% 10.54% 12.54% 12.86% 13.18%
Return on Assets (ROA)
8.11% 9.14% 8.97% 7.69% 7.21% 5.49% 1.80% 6.90% 8.56% 8.67% 9.60%
Return on Common Equity (ROCE)
18.50% 20.23% 18.66% 16.45% 15.91% 11.76% 3.82% 14.90% 18.22% 16.89% 17.45%
Return on Equity Simple (ROE_SIMPLE)
19.22% 19.34% 18.40% 19.01% 15.59% 12.00% 4.03% 15.95% 18.40% 17.19% 0.00%
Net Operating Profit after Tax (NOPAT)
454 539 578 514 484 407 156 573 743 620 768
NOPAT Margin
8.08% 9.45% 9.26% 8.17% 7.79% 6.80% 2.27% 7.21% 9.10% 8.35% 10.64%
Net Nonoperating Expense Percent (NNEP)
2.86% 2.70% 3.00% 3.69% 3.57% 2.89% 1.44% 2.85% 3.68% -1.89% 2.50%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 9.35% 11.94% 10.10% 11.71%
Cost of Revenue to Revenue
77.90% 75.44% 76.43% 78.25% 78.87% 78.75% 80.69% 81.20% 78.57% 75.90% 74.68%
SG&A Expenses to Revenue
0.00% 0.00% 9.87% 9.72% 9.82% 10.49% 9.69% 9.00% 9.67% 10.52% 11.29%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
10.35% 10.43% 10.19% 10.57% 10.44% 11.53% 14.81% 9.21% 9.71% 12.22% 11.25%
Earnings before Interest and Taxes (EBIT)
660 808 842 707 663 587 322 767 953 970 1,011
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
854 1,004 1,051 954 883 800 542 982 1,172 1,184 1,233
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.57 2.88 2.89 2.30 2.00 1.61 1.93 1.93 1.95 2.34 1.63
Price to Tangible Book Value (P/TBV)
4.86 5.77 5.23 4.83 3.66 2.97 3.41 3.29 3.09 3.51 2.31
Price to Revenue (P/Rev)
0.98 1.29 1.34 0.87 0.87 0.80 0.87 0.77 0.85 1.20 0.96
Price to Earnings (P/E)
13.70 15.22 16.07 12.39 13.14 13.69 51.09 12.36 10.73 13.77 9.54
Dividend Yield
2.26% 1.86% 1.90% 3.15% 3.09% 3.57% 2.87% 2.93% 2.82% 2.30% 2.94%
Earnings Yield
7.30% 6.57% 6.22% 8.07% 7.61% 7.31% 1.96% 8.09% 9.32% 7.26% 10.49%
Enterprise Value to Invested Capital (EV/IC)
1.90 2.14 2.23 1.74 1.62 1.35 1.53 1.49 1.57 1.98 1.48
Enterprise Value to Revenue (EV/Rev)
1.27 1.58 1.58 1.16 1.14 1.17 1.21 1.12 1.14 1.39 1.15
Enterprise Value to EBITDA (EV/EBITDA)
8.33 9.00 9.41 7.67 8.00 8.73 15.39 9.08 7.91 8.70 6.71
Enterprise Value to EBIT (EV/EBIT)
10.77 11.19 11.75 10.34 10.65 11.90 25.90 11.63 9.73 10.62 8.18
Enterprise Value to NOPAT (EV/NOPAT)
15.66 16.78 17.10 14.23 14.60 17.16 53.38 15.57 12.49 16.62 10.78
Enterprise Value to Operating Cash Flow (EV/OCF)
10.36 11.72 12.86 10.40 10.38 8.43 21.28 58.67 8.77 7.18 8.77
Enterprise Value to Free Cash Flow (EV/FCFF)
25.67 141.72 27.37 9.84 20.60 0.00 0.00 169.41 11.35 7.75 22.32
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.92 0.81 0.71 0.86 0.67 0.90 0.80 0.91 0.73 0.60 0.52
Long-Term Debt to Equity
0.91 0.77 0.67 0.79 0.64 0.76 0.70 0.74 0.61 0.58 0.51
Financial Leverage
0.67 0.66 0.55 0.60 0.64 0.63 0.69 0.76 0.72 0.47 0.31
Leverage Ratio
2.32 2.26 2.13 2.19 2.26 2.21 2.20 2.24 2.20 2.00 1.86
Compound Leverage Factor
2.10 2.07 1.94 1.92 1.98 1.90 1.69 1.95 1.94 1.92 1.79
Debt to Total Capital
47.95% 44.61% 41.46% 46.20% 40.00% 47.38% 44.35% 47.57% 42.23% 37.33% 34.14%
Short-Term Debt to Total Capital
0.45% 2.24% 2.38% 3.72% 1.77% 7.50% 5.31% 8.73% 7.09% 0.71% 0.72%
Long-Term Debt to Total Capital
47.49% 42.37% 39.08% 42.49% 38.23% 39.88% 39.03% 38.85% 35.14% 36.62% 33.41%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.86% 1.27% 1.23% 1.25% 1.13% 2.07% 2.16% 1.85% 1.77% 1.39% 1.39%
Common Equity to Total Capital
51.19% 54.13% 57.32% 52.54% 58.87% 50.55% 53.49% 50.58% 56.00% 61.29% 64.47%
Debt to EBITDA
2.35 2.11 1.99 2.20 2.09 3.46 4.74 3.01 2.28 1.96 1.84
Net Debt to EBITDA
1.84 1.59 1.41 1.85 1.79 2.63 4.13 2.77 1.93 1.11 1.00
Long-Term Debt to EBITDA
2.33 2.00 1.88 2.02 2.00 2.91 4.17 2.46 1.89 1.92 1.80
Debt to NOPAT
4.42 3.92 3.62 4.09 3.82 6.79 16.45 5.17 3.59 3.74 2.95
Net Debt to NOPAT
3.45 2.97 2.57 3.44 3.27 5.16 14.32 4.75 3.04 2.11 1.60
Long-Term Debt to NOPAT
4.38 3.73 3.41 3.76 3.65 5.72 14.48 4.22 2.99 3.66 2.89
Altman Z-Score
3.67 3.82 4.12 3.62 3.50 2.93 3.07 3.24 3.62 4.22 3.85
Noncontrolling Interest Sharing Ratio
1.50% 2.00% 2.19% 2.20% 2.09% 2.96% 3.91% 3.70% 3.28% 2.63% 2.16%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.63 2.30 2.52 2.26 2.23 1.82 1.78 1.76 1.92 2.62 2.66
Quick Ratio
1.64 1.47 1.64 1.36 1.29 1.15 0.97 0.88 0.95 1.64 1.69
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
277 64 361 743 343 -414 -134 53 817 1,330 371
Operating Cash Flow to CapEx
283.47% 274.38% 251.31% 201.43% 208.59% 248.95% 139.01% 51.88% 336.62% 486.78% 218.01%
Free Cash Flow to Firm to Interest Expense
4.54 0.97 4.95 8.64 4.23 -5.11 -1.81 0.53 7.16 34.11 10.02
Operating Cash Flow to Interest Expense
11.25 11.68 10.53 8.17 8.40 10.23 5.30 1.54 9.27 36.82 25.51
Operating Cash Flow Less CapEx to Interest Expense
7.28 7.42 6.34 4.12 4.37 6.12 1.49 -1.42 6.52 29.26 13.81
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.11 1.05 1.05 1.07 1.06 0.93 1.00 1.09 1.07 0.99 0.94
Accounts Receivable Turnover
7.31 6.72 6.63 6.58 6.44 6.02 6.44 6.25 6.07 6.26 6.34
Inventory Turnover
6.19 5.72 5.92 5.98 5.81 5.30 5.33 4.66 4.21 4.28 4.47
Fixed Asset Turnover
2.77 2.78 2.88 2.85 2.76 2.52 2.83 3.29 3.42 3.21 3.01
Accounts Payable Turnover
10.27 9.97 10.23 10.41 10.24 8.55 8.10 7.83 7.77 8.16 8.31
Days Sales Outstanding (DSO)
49.90 54.33 55.07 55.48 56.67 60.60 56.68 58.36 60.16 58.26 57.59
Days Inventory Outstanding (DIO)
58.93 63.79 61.65 61.08 62.80 68.82 68.53 78.32 86.74 85.34 81.72
Days Payable Outstanding (DPO)
35.55 36.60 35.68 35.05 35.63 42.69 45.04 46.59 47.00 44.73 43.91
Cash Conversion Cycle (CCC)
73.28 81.51 81.03 81.52 83.84 86.73 80.17 90.10 99.90 98.88 95.40
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,748 4,223 4,440 4,211 4,352 5,173 5,463 5,983 5,909 5,199 5,596
Invested Capital Turnover
1.54 1.43 1.44 1.45 1.45 1.26 1.30 1.39 1.37 1.34 1.34
Increase / (Decrease) in Invested Capital
177 475 217 -229 141 821 290 520 -74 -710 397
Enterprise Value (EV)
7,110 9,039 9,891 7,314 7,060 6,985 8,341 8,918 9,271 10,306 8,275
Market Capitalization
5,506 7,381 8,342 5,491 5,428 4,763 5,978 6,082 6,900 8,911 6,953
Book Value per Share
$29.97 $35.43 $40.23 $33.77 $40.74 $44.05 $46.59 $48.01 $54.27 $58.38 $67.28
Tangible Book Value per Share
$15.84 $17.67 $22.19 $16.08 $22.20 $23.96 $26.33 $28.16 $34.28 $38.98 $47.30
Total Capital
4,188 4,739 5,044 4,545 4,620 5,838 5,795 6,222 6,318 6,207 6,629
Total Debt
2,008 2,114 2,091 2,100 1,848 2,766 2,570 2,960 2,668 2,317 2,263
Total Long-Term Debt
1,989 2,008 1,971 1,931 1,766 2,328 2,262 2,417 2,220 2,273 2,215
Net Debt
1,568 1,598 1,487 1,766 1,580 2,101 2,238 2,721 2,259 1,309 1,230
Capital Expenditures (CapEx)
242 281 306 349 326 333 282 293 314 295 433
Debt-free, Cash-free Net Working Capital (DFCFNWC)
787 864 974 1,027 1,007 962 1,161 1,731 1,666 1,110 1,204
Debt-free Net Working Capital (DFNWC)
1,227 1,380 1,578 1,361 1,275 1,627 1,493 1,970 2,075 2,118 2,237
Net Working Capital (NWC)
1,208 1,274 1,458 1,192 1,193 1,189 1,185 1,427 1,627 2,074 2,189
Net Nonoperating Expense (NNE)
42 43 46 60 60 53 31 71 92 -34 32
Net Nonoperating Obligations (NNO)
1,568 1,598 1,487 1,766 1,580 2,101 2,238 2,721 2,259 1,309 1,230
Total Depreciation and Amortization (D&A)
194 196 209 247 220 213 220 215 219 214 222
Debt-free, Cash-free Net Working Capital to Revenue
14.00% 15.15% 15.60% 16.33% 16.22% 16.07% 16.84% 21.78% 20.42% 14.94% 16.68%
Debt-free Net Working Capital to Revenue
21.83% 24.19% 25.27% 21.64% 20.53% 27.18% 21.66% 24.79% 25.43% 28.51% 30.99%
Net Working Capital to Revenue
21.49% 22.34% 23.35% 18.95% 19.21% 19.86% 17.19% 17.96% 19.94% 27.91% 30.32%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$5.62 $6.70 $7.21 $6.25 $6.17 $5.18 $1.74 $7.43 $9.74 $9.88 $11.36
Adjusted Weighted Average Basic Shares Outstanding
71.60M 72.30M 72M 70.90M 66.90M 67.20M 67.10M 66.20M 66M 65.50M 64.20M
Adjusted Diluted Earnings per Share
$5.51 $6.55 $7.06 $6.17 $6.13 $5.15 $1.73 $7.34 $9.60 $9.71 $11.18
Adjusted Weighted Average Diluted Shares Outstanding
73M 74.10M 73.50M 71.80M 67.40M 67.60M 67.80M 67M 67M 66.60M 65.20M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
71.89M 71.79M 72.24M 66.67M 66.88M 67.11M 66.71M 65.95M 65.56M 64.19M 62.95M
Normalized Net Operating Profit after Tax (NOPAT)
855 939 605 561 525 472 351 576 751 709 784
Normalized NOPAT Margin
15.21% 16.47% 9.68% 8.92% 8.46% 7.89% 5.10% 7.24% 9.20% 9.55% 10.85%
Pre Tax Income Margin
10.66% 13.01% 12.32% 9.87% 9.37% 8.45% 3.60% 8.41% 10.28% 12.53% 13.49%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
10.82 12.24 11.53 8.22 8.19 7.25 4.35 7.75 8.36 24.87 27.32
NOPAT to Interest Expense
7.44 8.16 7.92 5.98 5.97 5.03 2.11 5.78 6.51 15.90 20.75
EBIT Less CapEx to Interest Expense
6.85 7.98 7.34 4.16 4.16 3.14 0.54 4.79 5.61 17.31 15.62
NOPAT Less CapEx to Interest Expense
3.47 3.91 3.73 1.92 1.95 0.92 -1.70 2.82 3.76 8.34 9.05
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
30.58% -28.43% 31.02% 40.09% 41.04% 50.28% 147.20% 36.06% 29.80% 32.11% 28.67%
Augmented Payout Ratio
40.53% -26.81% 54.14% 184.80% 25.47% 50.28% 201.60% 67.53% 45.62% 71.25% 59.10%

Quarterly Metrics And Ratios for Ingredion

This table displays calculated financial ratios and metrics derived from Ingredion's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 62,945,041.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 62,945,041.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 2.26
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.49% -3.32% -11.93% -9.23% -8.02% -6.30% -3.67% -2.40% -2.89% -2.39% -1.16%
EBITDA Growth
12.18% 20.19% 0.87% -3.29% 22.47% -16.02% -4.89% 10.20% -6.73% 26.98% -22.05%
EBIT Growth
14.05% 27.85% 1.37% -3.61% 29.86% -20.30% -6.44% 12.92% -9.49% 34.16% -26.45%
NOPAT Growth
49.51% 4.84% -22.82% -16.73% 0.72% -32.27% 22.27% 32.36% -4.22% 71.68% -26.75%
Net Income Growth
46.79% 15.65% 12.37% -8.54% 18.13% -27.07% -8.72% 32.00% -8.99% 72.16% -27.64%
EPS Growth
48.43% 15.20% 13.33% -8.26% 19.92% -27.41% -7.12% 34.68% -7.77% 80.42% -26.00%
Operating Cash Flow Growth
338.10% 469.44% 509.80% -5.45% 30.16% 6.34% -63.16% -40.71% -42.17% -7.11% -57.14%
Free Cash Flow Firm Growth
105.20% 160.54% 676.78% 1,015.83% 1,534.89% 258.87% -31.91% -85.52% -104.00% -126.99% -140.23%
Invested Capital Growth
2.40% -1.24% -8.04% -8.94% -8.67% -12.02% -4.36% 1.88% 3.76% 7.64% 6.09%
Revenue Q/Q Growth
-1.74% -5.51% -2.03% -0.21% -0.43% -3.74% 0.72% 1.10% -0.93% -3.25% 1.99%
EBITDA Q/Q Growth
-12.17% -4.12% 35.94% -15.52% 11.22% -34.25% 53.95% -2.11% -5.86% -10.49% -5.49%
EBIT Q/Q Growth
-15.26% -4.27% 46.04% -18.64% 14.17% -41.24% 71.43% -1.81% -8.49% -12.90% -6.02%
NOPAT Q/Q Growth
-1.99% -17.14% 10.21% -6.96% 18.54% -44.28% 98.98% 0.71% -14.22% -0.12% -15.10%
Net Income Q/Q Growth
-2.44% -16.88% 63.91% -31.19% 26.00% -48.68% 105.15% -0.50% -13.13% -2.91% -13.77%
EPS Q/Q Growth
-2.48% -16.53% 63.96% -31.27% 27.48% -49.47% 109.79% -0.33% -12.71% -1.15% -13.95%
Operating Cash Flow Q/Q Growth
11.52% 11.41% -49.02% 49.28% 53.53% -8.98% -82.34% 140.26% 49.73% 46.21% -91.85%
Free Cash Flow Firm Q/Q Growth
156.10% 424.45% 195.28% 5.42% 0.14% 15.12% -43.97% -77.58% -127.69% -675.92% 16.49%
Invested Capital Q/Q Growth
-2.17% -1.62% -3.00% -2.48% -1.88% -5.21% 5.44% 3.89% -0.07% -1.67% 3.93%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
20.71% 20.82% 22.16% 23.75% 25.62% 24.94% 25.70% 26.02% 25.06% 24.47% 22.38%
EBITDA Margin
13.13% 13.33% 18.49% 15.66% 17.49% 11.94% 18.26% 17.68% 16.80% 15.54% 14.40%
Operating Margin
10.48% 10.52% 11.32% 12.78% 14.33% 9.00% 15.22% 14.78% 13.71% 12.52% 11.33%
EBIT Margin
10.38% 10.52% 15.67% 12.78% 14.65% 8.94% 15.22% 14.78% 13.66% 12.29% 11.33%
Profit (Net Income) Margin
7.87% 6.92% 11.58% 7.99% 10.11% 5.39% 10.98% 10.80% 9.47% 9.50% 8.04%
Tax Burden Percent
86.49% 75.57% 78.99% 65.22% 69.23% 63.82% 74.53% 76.45% 71.37% 80.68% 74.23%
Interest Burden Percent
87.68% 87.13% 93.56% 95.83% 99.64% 94.41% 96.74% 95.57% 97.18% 95.83% 95.57%
Effective Tax Rate
13.51% 24.43% 21.01% 34.78% 30.77% 36.18% 25.47% 23.55% 28.63% 19.32% 25.77%
Return on Invested Capital (ROIC)
12.56% 10.91% 11.81% 10.96% 13.04% 7.68% 14.90% 14.65% 12.72% 13.51% 10.71%
ROIC Less NNEP Spread (ROIC-NNEP)
11.63% 10.12% 13.90% 10.67% 13.21% 7.33% 14.49% 14.09% 12.31% 12.68% 10.24%
Return on Net Nonoperating Assets (RNNOA)
9.14% 7.29% 9.23% 6.58% 7.04% 3.47% 6.15% 5.65% 4.16% 3.90% 3.38%
Return on Equity (ROE)
21.70% 18.19% 21.04% 17.55% 20.08% 11.15% 21.05% 20.30% 16.88% 17.41% 14.09%
Cash Return on Invested Capital (CROIC)
9.98% 13.73% 19.96% 20.65% 20.68% 23.95% 16.08% 10.57% 8.74% 6.87% 6.70%
Operating Return on Assets (OROA)
11.42% 11.29% 16.56% 13.30% 14.68% 8.81% 15.16% 14.42% 12.91% 11.57% 10.59%
Return on Assets (ROA)
8.66% 7.43% 12.24% 8.31% 10.13% 5.31% 10.93% 10.54% 8.96% 8.95% 7.51%
Return on Common Equity (ROCE)
21.00% 17.60% 20.45% 17.13% 19.59% 10.86% 20.59% 19.92% 16.54% 17.04% 13.87%
Return on Equity Simple (ROE_SIMPLE)
18.82% 0.00% 18.13% 17.84% 17.47% 0.00% 15.97% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
184 153 168 157 186 103 206 207 178 177 151
NOPAT Margin
9.06% 7.95% 8.94% 8.33% 9.92% 5.74% 11.35% 11.30% 9.79% 10.10% 8.41%
Net Nonoperating Expense Percent (NNEP)
0.93% 0.79% -2.08% 0.29% -0.17% 0.36% 0.40% 0.57% 0.40% 0.83% 0.48%
Return On Investment Capital (ROIC_SIMPLE)
- 2.45% - - - 1.68% 3.28% 3.18% 2.71% 2.71% 2.25%
Cost of Revenue to Revenue
79.29% 79.18% 77.84% 76.25% 74.39% 75.06% 74.30% 73.98% 74.94% 75.53% 77.62%
SG&A Expenses to Revenue
9.99% 10.98% 10.04% 10.17% 10.59% 11.33% 10.65% 11.35% 11.18% 12.01% 11.16%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
10.23% 10.31% 10.84% 10.97% 11.28% 15.94% 10.48% 11.24% 11.34% 11.95% 11.05%
Earnings before Interest and Taxes (EBIT)
211 202 295 240 274 161 276 271 248 216 203
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
267 256 348 294 327 215 331 324 305 273 258
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.88 1.95 2.03 2.02 2.25 2.34 2.17 2.07 1.84 1.63 1.61
Price to Tangible Book Value (P/TBV)
3.06 3.09 3.10 3.08 3.35 3.51 3.18 2.97 2.63 2.31 2.25
Price to Revenue (P/Rev)
0.77 0.85 0.96 0.97 1.18 1.20 1.17 1.19 1.07 0.96 0.98
Price to Earnings (P/E)
10.12 10.73 11.33 11.45 13.02 13.77 13.74 12.83 11.81 9.54 10.44
Dividend Yield
3.04% 2.82% 2.63% 2.68% 2.28% 2.30% 2.35% 2.36% 2.64% 2.94% 2.90%
Earnings Yield
9.88% 9.32% 8.83% 8.73% 7.68% 7.26% 7.28% 7.80% 8.47% 10.49% 9.57%
Enterprise Value to Invested Capital (EV/IC)
1.50 1.57 1.67 1.68 1.90 1.98 1.85 1.79 1.62 1.48 1.46
Enterprise Value to Revenue (EV/Rev)
1.09 1.14 1.21 1.21 1.38 1.39 1.38 1.39 1.27 1.15 1.18
Enterprise Value to EBITDA (EV/EBITDA)
7.95 7.91 8.15 8.04 8.51 8.70 8.68 8.49 7.86 6.71 7.27
Enterprise Value to EBIT (EV/EBIT)
9.88 9.73 10.00 9.88 10.31 10.62 10.65 10.35 9.66 8.18 8.98
Enterprise Value to NOPAT (EV/NOPAT)
12.24 12.49 13.81 14.15 15.63 16.62 15.55 14.49 13.31 10.78 11.89
Enterprise Value to Operating Cash Flow (EV/OCF)
12.49 8.77 7.27 7.21 7.39 7.18 7.77 8.64 9.47 8.77 9.41
Enterprise Value to Free Cash Flow (EV/FCFF)
15.16 11.35 8.02 7.73 8.78 7.75 11.24 17.04 18.92 22.32 22.37
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.83 0.73 0.61 0.61 0.58 0.60 0.56 0.53 0.53 0.52 0.51
Long-Term Debt to Equity
0.70 0.61 0.58 0.59 0.56 0.58 0.55 0.52 0.52 0.51 0.50
Financial Leverage
0.79 0.72 0.66 0.62 0.53 0.47 0.42 0.40 0.34 0.31 0.33
Leverage Ratio
2.25 2.20 2.08 2.04 2.01 2.00 1.88 1.86 1.84 1.86 1.81
Compound Leverage Factor
1.97 1.92 1.95 1.96 2.00 1.89 1.82 1.78 1.79 1.78 1.73
Debt to Total Capital
45.38% 42.23% 38.08% 38.05% 36.72% 37.33% 36.03% 34.85% 34.60% 34.14% 33.98%
Short-Term Debt to Total Capital
7.34% 7.09% 2.28% 1.79% 1.55% 0.71% 0.66% 0.70% 0.86% 0.72% 1.23%
Long-Term Debt to Total Capital
38.03% 35.14% 35.79% 36.26% 35.17% 36.62% 35.37% 34.15% 33.74% 33.41% 32.74%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.62% 1.77% 1.64% 1.21% 1.26% 1.39% 1.12% 1.20% 1.30% 1.39% 0.94%
Common Equity to Total Capital
53.00% 56.00% 60.29% 60.74% 62.02% 61.29% 62.85% 63.95% 64.10% 64.47% 65.09%
Debt to EBITDA
2.55 2.28 2.00 1.99 1.91 1.96 1.95 1.91 1.95 1.84 1.96
Net Debt to EBITDA
2.25 1.93 1.62 1.55 1.19 1.11 1.23 1.19 1.16 1.00 1.18
Long-Term Debt to EBITDA
2.14 1.89 1.88 1.90 1.83 1.92 1.92 1.87 1.90 1.80 1.89
Debt to NOPAT
3.93 3.59 3.39 3.51 3.51 3.74 3.50 3.26 3.30 2.95 3.21
Net Debt to NOPAT
3.46 3.04 2.75 2.74 2.18 2.11 2.20 2.02 1.97 1.60 1.92
Long-Term Debt to NOPAT
3.29 2.99 3.19 3.34 3.36 3.66 3.44 3.19 3.21 2.89 3.09
Altman Z-Score
3.22 3.30 3.74 3.74 3.92 3.87 3.95 3.85 3.69 3.51 3.55
Noncontrolling Interest Sharing Ratio
3.25% 3.28% 2.82% 2.37% 2.44% 2.63% 2.18% 1.90% 1.99% 2.16% 1.58%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.97 1.92 2.44 2.52 2.67 2.62 2.85 2.78 2.75 2.66 2.76
Quick Ratio
1.03 0.95 1.35 1.46 1.64 1.64 1.80 1.76 1.75 1.69 1.78
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
43 227 669 706 707 813 456 102 -28 -220 -183
Operating Cash Flow to CapEx
471.79% 493.98% 321.54% 567.27% 958.00% 348.80% 83.70% 183.17% 263.81% 300.00% 30.00%
Free Cash Flow to Firm to Interest Expense
1.66 8.72 35.22 70.55 706.54 90.38 50.63 8.51 -4.04 -24.39 -20.37
Operating Cash Flow to Interest Expense
14.15 15.77 11.00 31.20 479.00 48.44 8.56 15.42 39.57 45.00 3.67
Operating Cash Flow Less CapEx to Interest Expense
11.15 12.58 7.58 25.70 429.00 34.56 -1.67 7.00 24.57 30.00 -8.56
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.10 1.07 1.06 1.04 1.00 0.99 1.00 0.98 0.95 0.94 0.94
Accounts Receivable Turnover
5.91 6.07 5.77 5.82 5.92 6.26 5.73 5.53 5.84 6.34 5.45
Inventory Turnover
4.35 4.21 4.14 4.21 4.25 4.28 4.39 4.41 4.40 4.47 4.62
Fixed Asset Turnover
3.49 3.42 3.34 3.28 3.19 3.21 3.18 3.15 3.05 3.01 2.97
Accounts Payable Turnover
5.34 7.77 6.73 6.69 6.43 8.16 8.54 8.56 8.62 8.31 8.72
Days Sales Outstanding (DSO)
61.81 60.16 63.23 62.74 61.70 58.26 63.67 65.98 62.45 57.59 66.99
Days Inventory Outstanding (DIO)
83.95 86.74 88.14 86.62 85.96 85.34 83.17 82.69 82.87 81.72 79.08
Days Payable Outstanding (DPO)
68.29 47.00 54.23 54.60 56.74 44.73 42.74 42.63 42.33 43.91 41.87
Cash Conversion Cycle (CCC)
77.47 99.90 97.15 94.76 90.92 98.88 104.10 106.03 102.99 95.40 104.19
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
6,006 5,909 5,732 5,590 5,485 5,199 5,482 5,695 5,691 5,596 5,816
Invested Capital Turnover
1.39 1.37 1.32 1.32 1.31 1.34 1.31 1.30 1.30 1.34 1.27
Increase / (Decrease) in Invested Capital
141 -74 -501 -549 -521 -710 -250 105 206 397 334
Enterprise Value (EV)
8,980 9,271 9,574 9,364 10,424 10,306 10,132 10,168 9,238 8,275 8,473
Market Capitalization
6,338 6,900 7,566 7,479 8,889 8,911 8,627 8,670 7,785 6,953 7,040
Book Value per Share
$50.86 $54.27 $56.68 $56.44 $60.71 $58.38 $61.96 $65.26 $66.03 $67.28 $69.63
Tangible Book Value per Share
$31.27 $34.28 $37.11 $37.02 $40.81 $38.98 $42.27 $45.36 $46.20 $47.30 $49.63
Total Capital
6,347 6,318 6,177 6,100 6,369 6,207 6,328 6,563 6,612 6,629 6,734
Total Debt
2,880 2,668 2,352 2,321 2,339 2,317 2,280 2,287 2,288 2,263 2,288
Total Long-Term Debt
2,414 2,220 2,211 2,212 2,240 2,273 2,238 2,241 2,231 2,215 2,205
Net Debt
2,539 2,259 1,907 1,811 1,455 1,309 1,434 1,419 1,367 1,230 1,370
Capital Expenditures (CapEx)
78 83 65 55 50 125 92 101 105 135 110
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,746 1,666 1,538 1,468 1,311 1,110 1,379 1,431 1,374 1,204 1,413
Debt-free Net Working Capital (DFNWC)
2,087 2,075 1,983 1,978 2,195 2,118 2,225 2,299 2,295 2,237 2,331
Net Working Capital (NWC)
1,621 1,627 1,842 1,869 2,096 2,074 2,183 2,253 2,238 2,189 2,248
Net Nonoperating Expense (NNE)
24 20 -50 6.52 -3.46 6.38 6.71 9.17 5.71 10 6.68
Net Nonoperating Obligations (NNO)
2,539 2,259 1,907 1,811 1,455 1,309 1,434 1,419 1,367 1,230 1,370
Total Depreciation and Amortization (D&A)
56 54 53 54 53 54 55 53 57 57 55
Debt-free, Cash-free Net Working Capital to Revenue
21.23% 20.42% 19.46% 19.03% 17.36% 14.94% 18.73% 19.56% 18.92% 16.68% 19.63%
Debt-free Net Working Capital to Revenue
25.37% 25.43% 25.09% 25.64% 29.07% 28.51% 30.23% 31.42% 31.60% 30.99% 32.38%
Net Working Capital to Revenue
19.71% 19.94% 23.30% 24.23% 27.76% 27.91% 29.66% 30.80% 30.82% 30.32% 31.23%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.39 $2.00 $3.29 $2.25 $2.88 $1.46 $3.05 $3.04 $2.66 $2.61 $2.25
Adjusted Weighted Average Basic Shares Outstanding
66M 66M 65.70M 65.70M 65.30M 65.50M 64.50M 64.50M 64.30M 64.20M 63.20M
Adjusted Diluted Earnings per Share
$2.36 $1.97 $3.23 $2.22 $2.83 $1.43 $3.00 $2.99 $2.61 $2.58 $2.22
Adjusted Weighted Average Diluted Shares Outstanding
67M 67M 66.80M 66.80M 66.50M 66.60M 65.60M 65.60M 65.40M 65.20M 64M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
65.19M 65.56M 65.65M 65.06M 65.16M 64.19M 64.31M 64.18M 63.53M 62.95M 63.06M
Normalized Net Operating Profit after Tax (NOPAT)
193 153 171 172 194 160 211 209 180 184 159
Normalized NOPAT Margin
9.49% 7.99% 9.07% 9.13% 10.37% 8.90% 11.63% 11.43% 9.90% 10.47% 8.86%
Pre Tax Income Margin
9.10% 9.16% 14.67% 12.25% 14.60% 8.44% 14.73% 14.13% 13.27% 11.78% 10.83%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
8.12 7.77 15.53 24.00 274.00 17.89 30.67 22.58 35.43 24.00 22.56
NOPAT to Interest Expense
7.09 5.87 8.85 15.65 185.54 11.49 22.86 17.26 25.39 19.72 16.74
EBIT Less CapEx to Interest Expense
5.12 4.58 12.11 18.50 224.00 4.00 20.44 14.17 20.43 9.00 10.33
NOPAT Less CapEx to Interest Expense
4.09 2.68 5.43 10.15 135.54 -2.40 12.63 8.85 10.39 4.72 4.52
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
30.17% 29.80% 29.33% 30.71% 30.00% 32.11% 33.23% 31.04% 31.68% 28.67% 30.98%
Augmented Payout Ratio
47.39% 45.62% 44.74% 62.33% 48.41% 71.25% 82.05% 61.05% 71.17% 59.10% 58.88%

Financials Breakdown Chart

Key Financial Trends

Ingredion Inc. (INGR) shows solid cash generation and a solid balance sheet across the last four years, with 2025 delivering meaningful operating cash flow and a stable dividend. Revenue growth remains muted, and quarterly margins showed some compression into Q4 2025, but the company maintains a healthy financial position to fund the dividend and shareholder returns.

  • Strong operating cash flow in 2025, with net cash from continuing operating activities of 405 million in Q4 2025 (and positive cash flow in prior quarters), contributing to roughly $0.9B of operating cash for the year.
  • Healthy free cash flow for 2025: about $0.5B estimated after roughly $0.43B of capital expenditures, suggesting meaningful capacity to fund dividends and buybacks.
  • Gross margin generally in the mid-20s (roughly 24–26%), indicating stable profitability despite quarterly fluctuations in revenue and costs.
  • Dividend policy remains stable, with quarterly dividends per share around $0.80–$0.82 and a consistent cadence that supports income-oriented investors.
  • Debt levels are manageable and broadly stable (long-term debt around $2.2B–$2.3B; total liabilities around $3.5B; solid equity base around $4.0B–$4.3B), implying a conservative balance sheet for a manufacturing ingredients company.
  • Quarterly revenue oscillates in a narrow band around $1.8B without a clear growth trajectory, suggesting a flat to modestly sideways demand environment.
  • Operating income trended down modestly through 2025 (e.g., $276M in Q1 2025 to about $220M in Q4 2025), though it remained positive each quarter.
  • Earnings per share have been volatile (diluted EPS roughly in the $2.58–$3.00 range in 2025), influenced by changes in shares outstanding and quarterly mix.
  • Capex pacing is moderate, with quarterly purchases of PPE typically in the $90–135M range, implying ongoing capacity investment without extreme cash outlays.
  • Financing activities were negative in multiple quarters due to share repurchases and debt repayments (e.g., net cash from financing activities often negative), which reduces cash reserves even while operating cash remains solid.

Bottom line: Ingredion shows a resilient cash-generating engine and solid balance sheet, supporting dividends and healthy leverage. The challenges to watch are a lack of clear top-line growth and periodic margin pressure within 2025, plus a continued use of cash for share buybacks and debt management rather than aggressive investment—factors investors may weigh as they assess the stock's longer-term yield and growth prospects.

05/14/26 09:15 AM ETAI Generated. May Contain Errors.

Ingredion Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Ingredion's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Ingredion's net income appears to be on an upward trend, with a most recent value of $736 million in 2025, rising from $412 million in 2015. The previous period was $654 million in 2024. Check out Ingredion's forecast to explore projected trends and price targets.

Ingredion's total operating income in 2025 was $1.02 billion, based on the following breakdown:
  • Total Gross Profit: $1.83 billion
  • Total Operating Expenses: $812 million

Over the last 10 years, Ingredion's total revenue changed from $5.62 billion in 2015 to $7.22 billion in 2025, a change of 28.4%.

Ingredion's total liabilities were at $3.53 billion at the end of 2025, a 0.6% decrease from 2024, and a 22.0% increase since 2015.

In the past 10 years, Ingredion's cash and equivalents has ranged from $236 million in 2022 to $1.03 billion in 2025, and is currently $1.03 billion as of their latest financial filing in 2025.

Over the last 10 years, Ingredion's book value per share changed from 29.97 in 2015 to 67.28 in 2025, a change of 124.5%.



Financial statements for NYSE:INGR last updated on 5/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners